Treatment of Lichen Sclerosus at Extragenital Sites

When lichen sclerosus occurs at extragenital locations, management follows a specific evidence-based pathway distinct from genital disease. This protocol covers the recommended first-line approach for this presentation.

Clinical scenario

Extragenital lichen sclerosus — lichen sclerosus affecting skin sites outside the genital region.

Approach overview

First-line management involves topical corticosteroid therapy as the primary intervention, alongside a skin-barrier support strategy. Full regimen details, clinical decision points, and the complete step-by-step algorithm are available in the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/jdv.20083

We suggest ultrapotent or potent topical corticosteroids in patients with extragenital lichen sclerosus.

We suggest co-treatment with topical emollients in patients with extragenital lichen sclerosus.

View source ↗